drugset / Trial / NCT00612625

Near Normalisation of BG Improves the Potentiating Effect of GLP-1

NCT00612625

Completed 9 enrolled Hvidovre University Hospital
RandomizedSingle-groupSingle-blindBasic science

Summary

The ability of glucagon-like peptide 1 to enhance beta-cell responsiveness to I.v. glucose is impaired in patients with type 2 diabetes mellitus compared with healthy individuals. We investigated whether 4 weeks of near-normalisation og blood glucose improves the potentiation of glucose-stimulated insulin secretion by GLP-1

Timeline

Start
2004-02
Primary completion
2004-07
Completion
2004-12

Drugs

EvaluationDrugModalityDoseRoute
Subject GLP-1 Peptide 1.5 unknown Other